Your browser doesn't support javascript.
loading
Role of STAT3 in lung cancer.
Dutta, Pranabananda; Sabri, Nafiseh; Li, Jinghong; Li, Willis X.
Afiliação
  • Dutta P; Department of Medicine; University of California, San Diego ; La Jolla, CA USA.
  • Sabri N; Department of Medicine; University of California, San Diego ; La Jolla, CA USA ; Department of Chemistry & Molecular Biology; University of Gothenburg ; Gothenburg, Sweden.
  • Li J; Department of Medicine; University of California, San Diego ; La Jolla, CA USA.
  • Li WX; Department of Medicine; University of California, San Diego ; La Jolla, CA USA.
JAKSTAT ; 3(4): e999503, 2014.
Article em En | MEDLINE | ID: mdl-26413424
ABSTRACT
Lung cancer remains a challenging disease. It is responsible for the high cancer mortality rates in the US and worldwide. Elucidation of the molecular mechanisms operative in lung cancer is an important first step in developing effective therapies. Accumulating evidence over the last 2 decades suggests a critical role for Signal Transducer and Activator of Transcription 3 (STAT3) as a point of convergence for various signaling pathways that are dysregulated in the disease. In this review, we discuss possible molecular mechanisms involving STAT3 in lung tumorigenesis based on recent literature. We consider possible roles of STAT3 in cancer cell proliferation and survival, in the tumor immune environment, and in epigenetic regulation and interaction of STAT3 with other transcription factors. We also discuss the potential role of STAT3 in tumor suppression, which complicates strategies of targeting STAT3 in cancer therapy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAKSTAT Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAKSTAT Ano de publicação: 2014 Tipo de documento: Article